Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. OpGen, Inc.
  6. News
  7. Summary
    OPGN   US68373L3078

OPGEN, INC.

(OPGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Trade Lower Pre-Bell Monday

10/04/2021 | 09:11am EST


ę MT Newswires 2021
All news about OPGEN, INC.
11/12OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update - Form ..
PU
11/11OpGen, Inc. Provides Revenue Guidance for the Year 2021
CI
11/11Earnings Flash (OPGN) OPGEN Reports Q3 Revenue $1.2M, vs. Street Est of $1.2M
MT
11/11OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
11/11OpGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septem..
CI
11/04OpGen Corporate Presentation (PDF)
PU
11/04OpGen Appoints Albert Weber as Chief Financial Officer - Form 8-K
PU
11/04OPGEN INC : Change in Directors or Principal Officers, Other Events, Financial Statements ..
AQ
11/04Executive Video Interview with Oliver Schacht, Ph.D., OpGen CEO - Form 8-K
PU
11/04OPGEN INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
More news
Analyst Recommendations on OPGEN, INC.
More recommendations
Financials (USD)
Sales 2021 3,80 M - -
Net income 2021 -35,9 M - -
Net cash 2021 8,88 M - -
P/E ratio 2021 -1,59x
Yield 2021 -
Capitalization 61,5 M 61,5 M -
EV / Sales 2021 13,9x
EV / Sales 2022 9,16x
Nbr of Employees 102
Free-Float 99,7%
Chart OPGEN, INC.
Duration : Period :
OpGen, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPGEN, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,58 $
Average target price 4,18 $
Spread / Average Target 164%
EPS Revisions
Managers and Directors
Oliver Schacht President, Chief Executive Officer & Director
William E. Rhodes Non-Executive Chairman
Vadim Sapiro Chief Information Officer
Faranak Atrzadeh Chief Marketing & Scientific Affairs Officer
Johannes Bacher Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
OPGEN, INC.-19.12%64
MODERNA, INC.161.69%110 846
LONZA GROUP AG25.95%56 890
IQVIA HOLDINGS INC.48.11%50 694
SEAGEN INC.-1.11%31 671
CELLTRION, INC.-40.39%23 975